The purpose of this protocol is to demonstrate the placement of a delayed constricting device (an ameroid constrictor) around a coronary artery in a swine model. This device creates an ischemic area of the heart that is useful for studying new diagnostic imaging techniques and new methods of treatment.
Cardiovascular disease remains the number one cause of mortality in the United States. There are numerous approaches to treating these diseases, but regardless of the approach, an in vivo model is needed to test each treatment. The pig is one of the most used large animal models for cardiovascular disease. Its heart is very similar in anatomy and function to that of a human. The ameroid placement technique creates an ischemic area of the heart, which has many useful applications in studying myocardial infarction. This model has been used for surgical research, pharmaceutical studies, imaging techniques, and cell therapies.
There are several ways of inducing an ischemic area in the heart. Each has its advantages and disadvantages, but the placement of an ameroid constrictor remains the most widely used technique. The main advantages to using the ameroid are its prevalence in existing research, its availability in various sizes to accommodate the anatomy and size of the vessel to be constricted, the surgery is a relatively simple procedure, and the post-operative monitoring is minimal, since there are no external devices to maintain. This paper provides a detailed overview of the proper technique for the placement of the ameroid constrictor.
Coronary artery disease (CAD), which leads to myocardial ischemia, is the leading cause of disability, death, and health care costs around the world4 and attributable for approximately 1 out of every 3 deaths in the U.S.1,2,3,4,5,6. Although there have been many advances in both percutaneous and surgical treatments, as many as one third of patients suffering from CAD are ineligible for these treatments due to age, poor health, or suboptimal anatomy4,5,6,7. In order to evaluate new methods of diagnostic imaging or treatment, the development of an appropriate animal model is critical.
When developing an animal model for a disease, the induced disorder should closely emulate the anatomical and physiological characteristics of the disorder in humans8,9. One of the most widely used large animals for cardiovascular studies is the pig. The pig heart is most closely analogous to the human heart in terms of size, anatomy, and physiology3,6. Similar to the human heart, the myocardium of the pig's heart does not possess an extensive collateral circulation6. Because of this, the pig heart does not tolerate acute coronary occlusion well, but it can tolerate a gradual coronary occlusion. If a coronary artery is slowly occluded, it can be used as a model for chronic myocardial ischemia, chronic myocardial infarction, and heart failure5,6,9,10,11,12,13. Chronic myocardial ischemia can be induced through stent implantation or the placement of a hydraulic occluder, a fixed stenosis occluder, or an ameroid constrictor. There are advantages and disadvantages for all these methods which are outlined in detail in various publications6,9,13 but the most commonly used method is the ameroid placement5,6,10,11.
The ameroid constrictor consists of casein material encased within a stainless steel, plastic, or titanium ring. Once placed around an artery (usually the left anterior descending coronary artery (LAD) or the left circumflex coronary artery (LCX)), the casein material absorbs the surrounding fluid causing the inner lumen to narrow gradually, mimicking the slow stenosis of an artery and resulting finally in full occlusion9,13,14. This procedure used by itself or in conjunction with other methods results in a region of chronic myocardial ischemia and/or infarction of the left ventricle of the heart that has been useful for developing and evaluating new imaging techniques8,10,15, therapeutic treatments7,16,17,18 and surgical procedures19,20.
The procedures described here were approved by the National Heart, Lung, and Blood Institute Animal Care and Use Committee at the National Institutes of Health and conform to the policies outlined in The Public Health Service Policy on Humane Care and Use of Laboratory Animals, The Animal Welfare Act, and the Guide for the Care and Use of Laboratory Animals.
NOTE: The purpose of this surgical procedure is to produce an animal model of chronic myocardial ischemia that can be used to develop treatments that are clinically relevant for patients with severe CAD. This cannot be accomplished using an in vitro model.
1. Animals
2. Pre-surgical Procedures
3. Surgical Procedure
4. Post-operative
After analyzing the data obtained from ameroid placement surgeries performed in our facility over a two-year period, we found the survival rate to be 80%. The procedure was performed on 25 Yorkshire pigs weighing between 12 – 15 kg. Of the 25 pigs, 20 survived to the follow-up procedure, 2 fibrillated and died shortly after closing, 2 were euthanized for severe heart failure and pulmonary edema, and 1 had an anesthetic death during a follow-up radiograph. Necropsy revealed an infarcted area of the left ventricle in the animals that died within 24 hours of the procedure. It is suspected but could not be confirmed that the artery kinked due to the presence of the ameroid since the lumen of the ameroid was still open. The ameroids obtained from the animals that were euthanized due to heart failure were examined. There was total closure of the lumen at 18 days.
The surviving animals were imaged by Magnetic Resonance Imaging (MRI) at 28 days post-ameroid placement to measure the heart function and size of the ischemic area. Figure 2 and Figure 3 show the MRI images obtained from a pig with a titanium encased ameroid and a pig with a plastic encased ameroid, respectively. After imaging, a second thoracotomy was performed for either a cell injection or sham procedure. Animals were followed out as long as 16 weeks post-ameroid placement.
Figure 1: Images of the pig heart during the ameroid placement procedure. (A) Image of the pig heart showing the LAD, LCX, and obtuse marginal artery (OM). (B) Image of the dissected LCX artery before the ameroid placement. (C) Image of the proper placement of the ameroid around the LCX with the opening of the ameroid facing up or away from the heart. Please click here to view a larger version of this figure.
Figure 2: MRI image of pig heart with a titanium encased ameroid. MRI image of a pig heart taken four weeks after the placement of a titanium encased ameroid constrictor on the LCX artery. The arrow points to the artifact created by the titanium. Please click here to view a larger version of this figure.
Figure 3: MRI image of a pig heart with a plastic encased ameroid. MRI image of a pig heart taken four weeks after the placement of a plastic encased ameroid constrictor on the LCX artery. The arrow points to the ameroid constrictor. No artifact is observed. Please click here to view a larger version of this figure.
Ameroid constrictors have been used extensively to create animal models of chronic myocardial ischemia, chronic myocardial infarction, and heart failure5,6,7,9,10,11,12,13,15,16,17,18,19,22. Although these models can be created through the use of stents, hydraulic occluders, or fixed stenosis occluders, the prevalence of ameroid use in scientific literature allows researchers to more accurately compare the results of their work with previously published studies5,6,7,9,10,11,12,13,15,16,17,18,19,22. Another advantage of using the ameroid constrictor is that the procedure is relatively straightforward and can be performed successfully by anyone with reasonable surgical skills, and requires no specialized instruments. The other aforementioned methods require greater technical skills and, in the case of the hydraulic occluder, requires intense post-operative monitoring due to the externalized device6,13.
The main limitation of using the ameroid constrictor is the variability in the rate of occlusion9,13. In general, most studies using the ameroid constrictor have found the rate of stenosis to be highest in the first two weeks and then gradually taper off until complete occlusion occurs23,24. Ex vivo studies directly measuring the closure rate of the ameroid lumen have confirmed that the greatest reduction in lumen diameter occurs in the first two weeks and slows thereafter25,26. However, these same studies have also showed that surrounding glucose and protein concentrations can affect the rate and completeness of the ameroid closure, thereby suggesting that in vivo conditions are most likely responsible for the variability in ameroid occlusion rates25,26. Other investigators have suggested that mechanical trauma, inflammation, fibrosis, and thrombus formation caused by the ameroid placement procedure itself may contribute to this variability5,6,25. The latter scenario is most likely the reason for the premature deaths and heart failures observed in this study. It cannot be stressed enough the importance of doing delicate, yet adequate, artery dissection on either side of the ameroid to prevent kinking of the vessel.
Proper placement of the ameroid constrictor is critical to develop an ischemic area of the heart that is large enough to treat but not so large that it results in death. Placing the ameroid constrictor on the LCX before the first obtuse marginal branch appears to work best in Yorkshire pigs. As reported elsewhere, this resulted in an ischemic area of around 25-30% of the left ventricle6. Placing the ameroid any lower resulted in an ischemic area that was inadequate for the specific treatment that was being investigated in this study.
Arrhythmias occurring during the surgical procedure are rare. Administering oral amiodarone post-operation through the end of the study, may prevent arrhythmias during the 2 to 3 weeks post-operation, when the ameroid is closing off. Additionally, caretaking and medical staff should be especially vigilant in noting any coughing during this time, which could be an early sign of pulmonary edema/heart failure.
Over the years, the design of the ameroid constrictor has been improved upon. Ameroids are currently available in numerous sizes allowing the surgeon to select an ameroid that matches the diameter of the vessel to be occluded. The outer ring of the ameroid is available in stainless steel, titanium, or plastic. This is especially important when evaluating the affected hearts using MRI. All metal will cause an artifact on the MRI images. Titanium ameroids cause less of an artifact than stainless steel, while plastic leaves none at all. MRI images showing the difference between a titanium ameroid and a plastic ameroid are shown in Figure 2 and Figure 3, respectively. The artifact on the right side of the heart in Figure 2 is caused by the titanium ring encasing the ameroid. Until recently, the containment ring on the plastic ameroid was too bulky to place around a coronary artery without kinking the vessel. The ameroid constrictor used in this study (see Table of Materials) is a much more streamlined version, which has the same outer diameter as the metal ameroids.
The authors have nothing to disclose.
Intramural funding was provided for this project by the Division of Intramural Research, National Heart, Lung and Blood Institute at the National Institutes of Health. We would like to acknowledge Dr. James Hawkins, Dr. Robert Hoyt, The NIH Division of Veterinary Resources and the staff of the Cardiothoracic Surgery Research program at the NIH.
Anesthesia: ketamine | Putney, INC | Dose: 25mg/kg, IM | |
Anesthesia: midazolam | App Pharmaceuticals | Dose: 0.75mg/kg, IM | |
Anesthesia: isoflurane | Baxter | Dose: 1-3%, INH | |
Antibiotics: amoxicillin and clavulanate potassium | WG Critical Care | Dose: 15mg/kg, IV | |
Antibiotics: piperacillin and tazobactam | Fresenius Kabl | Dose: 100mg/kg, PO | |
Analgesia: buprenorphine (sustained release) | Zoo Pharm | 10mg/ml bottle, Dose: 0.2mg/kg SC | |
Analgesia: fentanyl patch | Mylan | Dose: 25-50mcg/hr, TD | |
Analgesia: bupivicaine 0.25% | Hospira | Give SC at incision site for analgesia | |
Alcohol 70% | Humco | NDC 0395-4202-28 | for scrubbing surgical site |
Chlorhexidine scrub 2% | Vet One | 510083 | for scrubbing surgical site |
Datex-Ohmeda Aestiva /5 anesthesia machine | GE Healthcare Madison WI. | ||
Pediatric anesthesia circuit | Westmed | 7-8901 | www.westmedinc.com |
Water blanket | Cincinnati Sub Zero | Blanketrol 2 | |
EKG | Medtronics- Physiocontrol | LifePak 20 | |
Oxygen saturation monitor | GE Healthcare Madison WI. | ||
Temperature probe | GE Healthcare Madison WI. | ||
Electrical cautery unit | Valley Labs | Force 2 | Cut-30 Coag-40 |
Endotracheal tube | Hudson RCI | HUD510312 | Hudson brand – appropriate size for animal |
Intravenous catheter, size 20 gauge | Santa Cruz Biotechnology, Inc | SC-360097 | Fluid and drug administration |
Lactated Ringers Solution | Hospira | NDC 0409-7953-03 | |
Macro IV drip set 15 drops/ml | Hospira | 12672-28 | |
Surgical gowns | Kimberly Clark | 90142 | |
Utility drapes | Kimberly Clark | 89731 | |
Adult laparotomy drape | Medline | DYNJP3004 | |
Sterile surgical gloves | Cardinal Health (Allegiance) | 22537-570 | Size 7 – use appropriate size for surgeon |
Needle mat – sterile | Medline | NC30MBR | |
Cautery pencil | Medline | ESPB 2000 | |
Suction tubing | Medline | DYND50251 | |
Suction tip; Yankauer | Medline | DYND50130 | |
Suction cannister | Cardinal Health (Allegiance) | 65651-220 | |
Ameroid constrictors sizes 2.5mm -3.5mm | Research Instruments SW, Inc. | 760-764-9411 | Types: Stainless steel, titanium, or plastic |
3-way stopcock | Cardinal Health (Allegiance) | 455991 | For chest tube |
Stomach tube – 18 Fr | Cardinal Health (Allegiance) | DC4418 | For chest tube |
60cc syringe | Cardinal Health (Allegiance) | SY35060LL | For chest tube |
3cc syringe | Cardinal Health (Allegiance) | SY35003LL | For post-op analgesia injection |
Skin stapler – 35W | Ethicon Endo-Surgery | PMW 35 | skin closure |
Scalpel blade – size #10 | Cardinal Health (Allegiance) | 32295-010 | |
Mini silicone vessel loops 1 Pak | Aspen Surgical | 011001PBX | for elevating circumflex artery to apply ameroid |
1 (polypropylene) taper | Ethicon | BB #8425H | close ribs |
2-0 (polypropylene) taper | Ethicon | SH #8523 | close muscle layers |
4-0 (polypropylene) taper | Ethicon | BB #8581H | close pericardium |
20 gauge needle | Cardinal Health (Allegiance) | 81-200219 | post-op analgesia injection |
antimicrobial drape | 3M | 6640EZ | |
Finochietto rib retractor – infant size | Codman | 50-8057 | |
Potts-Smith scissors | Roboz | RS-6043 | |
Babcock forceps | Roboz | RS-8022 | |
Pean hemostatic forceps curved | Codman | 30-4565 | |
scalpel handle #7 | Codman | 11-5534 | |
Brown Adson forceps | Roboz | RS-5231 | |
Debakey forceps | Roboz | RS-7562 | |
Mayo scissors | Roboz | RS-6870SC | |
Metzenbaum dissecting scissors | Codman | 36-5011 | |
Metzenbaum dissecting scissors | Codman | 36-5016 | |
Mayo-Hegar needle holder | Codman | 36-2017 | |
Ryder needle holder | Codman | 36-3012 | |
Kelly hemostatic forceps | Roboz | RS-7130 | |
Reynolds hemostatic forcep | Roboz | RS-7211 | |
Weitlander retractor | Roboz | RS-8612 | |
Yorkshire domestic pigs |